Related Experiment Video
Updated: Aug 5, 2025

07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
11.1K
Community data-driven approach to identify pathogenic founder variants for pan-ethnic carrier screening panels
Yaron Einhorn1, Moshe Einhorn1, Alina Kurolap2
1Genoox, Tel Aviv, Israel.
Human Genomics
|March 28, 2023
Summary
A community-driven approach using exome data identified new pathogenic founder variants (PFVs) for carrier screening panels. This method enhances genetic screening inclusivity and equity for diverse ethnic groups.
Area of Science:
- Genetics
- Bioinformatics
- Public Health
Background:
- New American College of Medical Genetics and Genomics (ACMG) guidelines recommend tier-based carrier screening.
- Pathogenic founder variants (PFVs) are often specific to certain ethnic groups.
- Existing screening panels may not cover all relevant genetic disorders for diverse populations.
Purpose of the Study:
- To demonstrate a community data-driven approach for developing a pan-ethnic carrier screening panel.
- To align carrier screening with ACMG recommendations.
- To identify novel PFVs in underrepresented ethnic groups.
Main Methods:
- Exome sequencing data from 3061 Israeli individuals were analyzed.
- Machine learning was used for ancestry determination and variant frequency calculation.
- Candidate PFVs were curated using community data (Franklin platform) and literature review.
Main Results:
- Samples were assigned to 13 ancestries, with Ashkenazi Jewish and Muslim Arab being the largest groups.
- Seven tier-3 and one tier-2 variants, absent in current panels, were identified for these ancestries.
- Five of these variants were validated by community evidence; 20 additional potentially pathogenic variants were detected.
Conclusions:
- Community data-driven and sharing approaches enable the creation of inclusive and equitable ethnically based carrier screening panels.
- This method successfully identified novel PFVs not present in existing screening panels.
- The findings highlight the need for reclassification of certain genetic variants and improved ethnic representation in screening.
Keywords:
ACMGCarrier screeningCommunity data-driven approachGenomicsPan-ethnicPathogenic founder variantsMore Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
13.7K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.7K
Single Nucleotide Polymorphisms-SNPs
15.4K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.4K
Genetic Screens
5.0K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.0K

